Alzheimer's disease (AD) is the most prevalent neurodegenerative disease in ageing,
affecting around 46 million people worldwide but few treatments are currently available. The …

Abstract Three-dimensional (3D) printing is a revolutionary technology that is disrupting
pharmaceutical development by enabling the production of personalised printlets (3D …

Alzheimer's dementia (AD) is increasingly being recognized as one of the most important
medical and social problems in older people in industrialized and non-industrialized …

Alzheimer's disease (AD) is the most common type of senile dementia, characterized by
neurofibrillary tangle and amyloid plaque in brain pathology. Major efforts in AD drug were …

The β‐site APP cleaving enzymes 1 and 2 (BACE 1 and BACE 2) were initially identified as
transmembrane aspartyl proteases cleaving the amyloid precursor protein (APP). BACE 1 is …

Importance Early identification of Alzheimer disease (AD) is important for clinical
management and affords the opportunity to assess potential disease-modifying agents in …

Alzheimer's disease (AD) is a neurodegenerative disease, characterized by progressive loss
of memory which is associated with other cognitive deficits. The two protein structures in the …

Alzheimer's disease (AD) is a neurodegenerative disorder linked to protein misfolding and
aggregation. AD is pathologically characterized by senile plaques formed by extracellular …

Alzheimer's disease (AD) is the most prevalent form of dementia, characterized by the
presence of plaques of amyloid beta and Tau proteins. There is currently no permanent cure …

Cerebrospinal fluid and positron emission tomography biomarkers accurately predict an
underlying Alzheimer's disease (AD) pathology; however, they represent either invasive or …